1e
19
1
49
2
2
18
1b
1d
18
2c
47
1d
2 29
1d
25
Susan Roth, MD
78
47
Emeritus Professor CE of Radiology
28
b6
3
60
Active Staff, Department of Radiology, Presbyterian Medical Center, University of Pennsylvania Health Systems; Philadelphia, PA
11
Department: Radiology
4
1
b
1d
46
Contact information
45
4
3
3
3
2
4
b
1f
45
Department of Radiology
33 Hospital of the University of Pennsylvania
36 3400 Spruce Street
Philadelphia, PA 19104
26
33 Hospital of the University of Pennsylvania
36 3400 Spruce Street
Philadelphia, PA 19104
2e
Office: 215-614-0124
32 Fax: 215-662-7436
24
93
32 Fax: 215-662-7436
24
Email:
susan.roth@uphs.upenn.edu
12
susan.roth@uphs.upenn.edu
13
Education:
21 5 c
2b Cornell University, 1977.
21 7 BA c
33 University of Pennsylvania, 1979.
21 9 M.D. c
46 School of Medicine University of Pennsylvania, 1984.
c
3
3
3
3
8b
Permanent link21 5 c
2b Cornell University, 1977.
21 7 BA c
33 University of Pennsylvania, 1979.
21 9 M.D. c
46 School of Medicine University of Pennsylvania, 1984.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
1a Breast MRI65
Description of Clinical Expertise
57 Breast Imaging (mammography, US, MRI, breast interventional procedures)1a 29
23
c2 Friedlander LC, Roth SO, Gavenonis SC.: Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. 3b Radiology 261(2): 421-7, Nov 2011.
c9 Han BK, Schnall MD, Orel SG, Rosen M.: Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol 191(6): 1798-804, December 2008.
b0 Han BK, Schnall MD, Orel S, Rosen M: Outcome of MRI-guided breast biopsy. AJR 191: 1798, December 2008.
b5 Orel S: Who should have breast magnetic resonance imaging evaluation? J Clin Oncol 26(5): 703-711, Feb 2008.
11f Weinstein SP, Orel SG, Pinnamaneni N, Tchou J, Czerniecki B, Boraas M, Rosato E, Solin LJ: Mammographic appearance of recurrent breast cancer after breast conservation therapy. Acad Radiol 15(2): 240-244, Feb 2008.
156 Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26(3): 386-391, Jan 2008.
13d Vapiwala N, Starzyk J, Harris EE, Tchou JC, Boraas MC, Czerniecki BJ, Rosato EF, Orel SG, Solin LJ: Biopsy findings after breast conservation therapy for early stage invasive breast cancer. Int J Radiat Oncol Biol Phys 69(2): 490-497, Oct 2007.
1c0 Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ: Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 67(4): 1842-1852, Feb 2007.
bf Schnall M, Orel S: Breast MR imaging in the diagnostic setting. Magn Reson Imaging Clin N Am 14(3): 329-337, Aug 2006.
2c
7
1d
1f
Selected Publications
ff Roth RG, Maidment AD, Weinstein SP, Roth SO, Conant EF: Digital breast tomosynthesis: lessons learned from early clinical implementation. Radiographics 34(4): E89-E102, Jul-Aug 2014.c2 Friedlander LC, Roth SO, Gavenonis SC.: Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. 3b Radiology 261(2): 421-7, Nov 2011.
c9 Han BK, Schnall MD, Orel SG, Rosen M.: Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol 191(6): 1798-804, December 2008.
b0 Han BK, Schnall MD, Orel S, Rosen M: Outcome of MRI-guided breast biopsy. AJR 191: 1798, December 2008.
b5 Orel S: Who should have breast magnetic resonance imaging evaluation? J Clin Oncol 26(5): 703-711, Feb 2008.
11f Weinstein SP, Orel SG, Pinnamaneni N, Tchou J, Czerniecki B, Boraas M, Rosato E, Solin LJ: Mammographic appearance of recurrent breast cancer after breast conservation therapy. Acad Radiol 15(2): 240-244, Feb 2008.
156 Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26(3): 386-391, Jan 2008.
13d Vapiwala N, Starzyk J, Harris EE, Tchou JC, Boraas MC, Czerniecki BJ, Rosato EF, Orel SG, Solin LJ: Biopsy findings after breast conservation therapy for early stage invasive breast cancer. Int J Radiat Oncol Biol Phys 69(2): 490-497, Oct 2007.
1c0 Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ: Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 67(4): 1842-1852, Feb 2007.
bf Schnall M, Orel S: Breast MR imaging in the diagnostic setting. Magn Reson Imaging Clin N Am 14(3): 329-337, Aug 2006.
2c